Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/TAKEDA-PHARMACEUTICAL-COM-6491073/news/Takeda-erhalt-positive-CHMP-Stellungnahme-fur-HYQVIA-als-Erhaltungstherapie-bei-Patienten-mit-ch-45585107/?utm_source=whatsapp&utm_medium=social&utm_campaign=share